TY - JOUR
T1 - Left ventricular dyssynchrony in patients with heart failure and preserved ejection fraction
AU - Santos, Angela B S
AU - Kraigher-Krainer, Elisabeth
AU - Bello, Natalie
AU - Claggett, Brian
AU - Zile, Michael R.
AU - Pieske, Burkert
AU - Voors, Adriaan A.
AU - McMurray, John J V
AU - Packer, Milton
AU - Bransford, Toni
AU - Lefkowitz, Marty
AU - Shah, Amil M.
AU - Solomon, Scott D.
N1 - Funding Information:
PARAMOUNT trial was funded by Novartis Pharmaceuticals, East Hanover, NJ, USA. A.B.S.S. acknowledges a grant support (0281-12-3) from CAPES (Brazil).
PY - 2014/1/1
Y1 - 2014/1/1
N2 - AimsMechanical dyssynchrony has been postulated to play a pathophysiologic role in heart failure with preserved ejection fraction (HFpEF).Methods and resultsWe quantified left ventricular (LV) systolic dyssynchrony in 130 HFpEF patients with NYHA class II-IV symptoms, ejection fraction (EF) ≥45%, and NT-proBNP levels >400 pg/mL enrolled in the PARAMOUNT trial, and compared them to 40 healthy controls of similar age and gender. Dyssynchrony was assessed by 2D speckle tracking as standard deviation (SD) of time to peak longitudinal systolic strain in 12 ventricular segments and related to measures of systolic and diastolic function. Heart failure with preserved ejection fraction patients (62% women, mean age of 71 ± 9 years, body mass index of 30.2 ± 5.9 kg/m2, systolic blood pressure 139 ± 15 mmHg) demonstrated significantly greater dyssynchrony than controls (SD of time to peak longitudinal strain; 90.6 ± 50.9 vs. 56.4 ± 33.5 ms, P < 0.001), even in the subset of patients (n = 63) with LVEF ≥55% and narrow QRS (≤100 ms). Among HFpEF patients, dyssynchrony was related to wider QRS interval, higher LV mass, and lower early diastolic tissue Doppler myocardial velocity (E′). Greater dyssynchrony remained significantly associated with worse diastolic function even after restricting the analysis to patients with EF≥55% and adjusting for age, gender, systolic blood pressure, LV mass index, and LVEF.ConclusionHeart failure with preserved EF is associated with greater mechanical dyssynchrony compared with healthy controls of similar age and gender. Within an HFpEF population, the severity of dyssynchrony is related to the width of QRS complex, LV hypertrophy, and diastolic dysfunction.
AB - AimsMechanical dyssynchrony has been postulated to play a pathophysiologic role in heart failure with preserved ejection fraction (HFpEF).Methods and resultsWe quantified left ventricular (LV) systolic dyssynchrony in 130 HFpEF patients with NYHA class II-IV symptoms, ejection fraction (EF) ≥45%, and NT-proBNP levels >400 pg/mL enrolled in the PARAMOUNT trial, and compared them to 40 healthy controls of similar age and gender. Dyssynchrony was assessed by 2D speckle tracking as standard deviation (SD) of time to peak longitudinal systolic strain in 12 ventricular segments and related to measures of systolic and diastolic function. Heart failure with preserved ejection fraction patients (62% women, mean age of 71 ± 9 years, body mass index of 30.2 ± 5.9 kg/m2, systolic blood pressure 139 ± 15 mmHg) demonstrated significantly greater dyssynchrony than controls (SD of time to peak longitudinal strain; 90.6 ± 50.9 vs. 56.4 ± 33.5 ms, P < 0.001), even in the subset of patients (n = 63) with LVEF ≥55% and narrow QRS (≤100 ms). Among HFpEF patients, dyssynchrony was related to wider QRS interval, higher LV mass, and lower early diastolic tissue Doppler myocardial velocity (E′). Greater dyssynchrony remained significantly associated with worse diastolic function even after restricting the analysis to patients with EF≥55% and adjusting for age, gender, systolic blood pressure, LV mass index, and LVEF.ConclusionHeart failure with preserved EF is associated with greater mechanical dyssynchrony compared with healthy controls of similar age and gender. Within an HFpEF population, the severity of dyssynchrony is related to the width of QRS complex, LV hypertrophy, and diastolic dysfunction.
KW - Dyssynchrony
KW - Heart failure with preserved ejection fraction
KW - Speckle tracking
UR - http://www.scopus.com/inward/record.url?scp=84891762632&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84891762632&partnerID=8YFLogxK
U2 - 10.1093/eurheartj/eht427
DO - 10.1093/eurheartj/eht427
M3 - Article
C2 - 24164863
AN - SCOPUS:84891762632
SN - 0195-668X
VL - 35
SP - 42
EP - 47
JO - European Heart Journal
JF - European Heart Journal
IS - 1
ER -